Mars WM - Search Results

1

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Yang J, Shultz RW, Mars WM, Wegner RE, Li Y, Dai C, Nejak K, Liu Y. Yang J, et al. Among authors: mars wm. J Clin Invest. 2002 Nov;110(10):1525-38. doi: 10.1172/JCI16219. J Clin Invest. 2002. PMID: 12438450 Free PMC article.

2

Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.

Hu K, Wu C, Mars WM, Liu Y. Hu K, et al. Among authors: mars wm. J Clin Invest. 2007 Dec;117(12):3821-32. doi: 10.1172/JCI32301. J Clin Invest. 2007. PMID: 18037995 Free PMC article.

3

Novel actions of tissue-type plasminogen activator in chronic kidney disease.

Hu K, Mars WM, Liu Y. Hu K, et al. Among authors: mars wm. Front Biosci. 2008 May 1;13:5174-86. doi: 10.2741/3073. Front Biosci. 2008. PMID: 18508579 Free PMC article. Review.

4

Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression.

Hu K, Yang J, Tanaka S, Gonias SL, Mars WM, Liu Y. Hu K, et al. Among authors: mars wm. J Biol Chem. 2006 Jan 27;281(4):2120-7. doi: 10.1074/jbc.M504988200. Epub 2005 Nov 22. J Biol Chem. 2006. PMID: 16303771 Free article.

5

tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis.

Hu K, Lin L, Tan X, Yang J, Bu G, Mars WM, Liu Y. Hu K, et al. Among authors: mars wm. J Am Soc Nephrol. 2008 Mar;19(3):503-14. doi: 10.1681/ASN.2007030300. Epub 2008 Jan 16. J Am Soc Nephrol. 2008. PMID: 18199803 Free PMC article.

6

tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling.

Hao S, Shen H, Hou Y, Mars WM, Liu Y. Hao S, et al. Among authors: mars wm. Am J Pathol. 2010 Sep;177(3):1164-75. doi: 10.2353/ajpath.2010.091269. Epub 2010 Jul 16. Am J Pathol. 2010. PMID: 20639453 Free PMC article.

7

Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1.

Kang LI, Isse K, Koral K, Bowen WC, Muratoglu S, Strickland DK, Michalopoulos GK, Mars WM. Kang LI, et al. Among authors: mars wm. Lab Invest. 2015 Oct;95(10):1117-29. doi: 10.1038/labinvest.2015.94. Epub 2015 Aug 3. Lab Invest. 2015. PMID: 26237273 Free PMC article.

8

Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways.

Lin L, Jin Y, Mars WM, Reeves WB, Hu K. Lin L, et al. Among authors: mars wm. Am J Pathol. 2014 Oct;184(10):2757-67. doi: 10.1016/j.ajpath.2014.06.013. Epub 2014 Aug 12. Am J Pathol. 2014. PMID: 25131752 Free PMC article.

9

A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes.

Coudriet GM, Stoops J, Orr AV, Bhushan B, Koral K, Lee S, Previte DM, Dong HH, Michalopoulos GK, Mars WM, Piganelli JD. Coudriet GM, et al. Among authors: mars wm. Am J Pathol. 2019 Jul;189(7):1413-1422. doi: 10.1016/j.ajpath.2019.04.004. Epub 2019 May 2. Am J Pathol. 2019. PMID: 31054988 Free article.

10

Stressed erythrophagocytosis induces immunosuppression during sepsis through heme-mediated STAT1 dysregulation.

Olonisakin TF, Suber T, Gonzalez-Ferrer S, Xiong Z, Peñaloza HF, van der Geest R, Xiong Y, Osei-Hwedieh DO, Tejero J, Rosengart MR, Mars WM, Van Tyne D, Perlegas A, Brashears S, Kim-Shapiro DB, Gladwin MT, Bachman MA, Hod EA, St Croix C, Tyurina YY, Kagan VE, Mallampalli RK, Ray A, Ray P, Lee JS. Olonisakin TF, et al. Among authors: mars wm. J Clin Invest. 2021 Jan 4;131(1):e137468. doi: 10.1172/JCI137468. J Clin Invest. 2021. PMID: 32941182 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page